{
    "2021-04-23": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Roche, AbbVie, Bristol-Myers Are Latest To Win European Medicines Agency's CHMP Positive Opinion",
                "features": {
                    "keywords": [
                        "Roche",
                        "AbbVie",
                        "Bristol-Myers",
                        "European Medicines Agency",
                        "CHMP Positive Opinion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "What's in the Cards for AbbVie (ABBV) This Earnings Season?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Earnings Season"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-22",
                "original_text": "AbbVie Receives Positive CHMP Opinion for VENCLYXTOÂ® (venetoclax) as a Combination Regimen for Adult Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "VENCLYXTO",
                        "CHMP Opinion",
                        "Acute Myeloid Leukemia",
                        "Combination Regimen"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}